COMPOSITION FOR GLOMERULOPATHY TREATMENT AND PROPHYLAXIS, NOVEL COMPOUNDS COMPRISING TO THEREOF, PHARMACEUTICAL COMPOSITION FOR INHIBITION OF MATRIX METALLOPROTEINASES ACTIVITY AND COMPOSITION FOR INHIBITION OF COLLAGENASES OF TYPE IV Russian patent published in 2003 - IPC

Abstract RU 2207849 C2

FIELD: organic chemistry, medicine, biochemistry, pharmacy. SUBSTANCE: invention describes composition used for treatment and prophylaxis of glomerulopathy that comprises compound of the formula (I) where R1 means hydrogen atom, (lower) alkyl, optionally substituted -CONHPh or (lower) alkylthio-group, phenyl, optionally substituted hydroxy-group, phenyl-(lower)-alkyl or indole-3-yl-(lower)-alkyl, optionally substituted (lower) alkoxy-group; R2 means hydrogen atom or (lower) alkyl; R3 means 1,4-phenylene or 2,5-thiophenediyl; R4 means a substituent represented by structural fragments (a) , (b) , (c) , (d) , (e) , (f) , (g) , (j) , (k) or (l) where R5 means hydrogen atom, hydroxy-group, (lower) alkoxy-group, optionally substituted dialkylamino-group, (lower) alkylthio-group, halogen atom, (lower) halide alkyl, amino-group optionally substituted with (lower) alkyl, (lower) alkyl optionally substituted with azido-group or hydroxy-group, nitro-group, cyano-group, acyl group, -CONH2, -NHCORD where RD means (lower)-alkyl, morpholino-group; R6 means phenyl, (lower) alkyl optionally substituted with hydroxy-group, (lower) alkyloxy-group, (lower) alkylthio-group, amino-group optionally substituted with (lower) alkyl, morpholino-group or 1-pyrrolidinyl and Y means NHOH or OH, its optically active isomer, pharmaceutically acceptable salt or hydrate. Invention describes also: novel compounds of formulas: (XVII) , (XVIII) , (XIX) , (XX) , (XXII) and (XXIII) where R1 has values indicated above and values R14 and R10 fall within values R5 and R2, respectively, and pharmaceutical composition used for inhibition of matrix metalloproteinases activity and composition for inhibition of activity of collagenases of type IV. EFFECT: valuable medicinal and biochemical properties of compounds and composition. 37 cl, 13 tbl, 5 dwg, 121 ex

Similar patents RU2207849C2

Title Year Author Number
PARA-TERPHENYL COMPOUNDS, METHOD OF THEIR SYNTHESIS (VERSIONS) AND PHARMACEUTICAL COMPOSITION (VERSIONS) 1997
  • Kavada Kendzhi
  • Okhtani Mitsuaki
  • Suzuki Rjudzhi
  • Arimura Akinori
RU2200730C2
NOVEL TRICYCLIC DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR INHIBITION OF IMMUNE RESPONSE OR TREATMENT AND/OR PROPHYLAXIS OF ALLERGIC DISEASES (VARIANTS) 1999
  • Tanimoto Norikhiko
  • Khasegava Jasushi
  • Khaga Nobukhiro
RU2216533C2
SULFATED AMINO ACID DERIVATIVES AND METALLOPROTEINASE INHIBITORS COMPRISING THEREOF 1997
  • Vatanabe Fumikhiko
  • Tsuzuki Khiroshige
  • Okhtani Mitsuaki
RU2198656C2
AROMATIC HETEROCYCLIC COMPOUNDS ELICITING ACTIVITY WITH REGARDS TO HIV-INTEGRASE 1999
  • Fudzishita Toshio
  • Eshinaga Tomokatsu
  • Sato Akikhiko
RU2225860C2
DERIVATIVES OF INDOLE ELICITING ANTIVIRAL ACTIVITY 1999
  • Fudzhishita Toshio
  • Eshinaga Tomokatsu
RU2217421C2
CEPHEM DERIVATIVES, METHOD FOR THEIR PREPARING, COMPOUND, PHARMACEUTICAL COMPOSITION, TREATMENT METHOD 1999
  • Nishitani Jasukhiro
  • Itani Khikaru
  • Irie Tadashi
RU2223964C2
INHIBITORS OF TH2-DIFFERENTIATION 2000
  • Arimura Akinori
  • Kavada Kendzhi
RU2230551C2
OXADIAZOLE DERIVATIVES POSSESSING ANTI-TUMOR EFFECT, MEDICINAL AGENT COMPRISING THEREOF AND METHOD FOR TREATMENT 2001
  • Eshioka Takajuki
  • Maekava Rjuji
  • Vatanabe Fumikhiko
RU2275371C2
PYRROLIDINE DERIVATIVES EXHIBITING INHIBITORY ACTIVITY WITH RESPECT TO PHOSPHOLIPASE A 1998
  • Seno Kaori
  • Okhtani Mitsuaki
  • Vatanabe Fumikhiko
RU2198174C2
BENZOTHIOPHEMECARBOXAMIDE DERIVATIVES, ANTAGONISTS OF PROSTAGLANDIN D CONTAINING THEREOF, PHARMACEUTICAL COMPOSITION AND DRUG 1997
  • Khonma Tsunetoshi
  • Khiramatsu Joshikharu
  • Arimura Akinori
RU2161617C1

RU 2 207 849 C2

Authors

Kurikhara Khidetake

Vatanabe Fumikhiko

Tamura Joshinori

Sinosaki Toshikhiro

Dates

2003-07-10Published

1998-07-17Filed